AzTrials
AzTrials

Radiation ExposureRADIANTNCT01974453

RAdiation Dose In percutANeuos Coronary Procedures Through Transradial Approach (RADIANT Observational Study)

An observational study of Radiation Exposure, run by Ospedale Sandro Pertini, Roma at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Radiation issue during percutaneous coronary interventions is an important issue for operators due to the long term stochastic risk of cancer induction, but is often under-evaluated. Many factors may be associated with the radiation dose adsorbed by operators. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Radiation Exposure
What is being tested?
Radiation dose
Type of treatment
Surgery or procedure
How many people
2,028 participants
Where
1 siteItaly
Study dates
Aug 2012to Feb 2016
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Medical operators that performe diagnostic and interventional coronary procedures

Who may be able to join

  • All patients who underwent to percutaneous coronary diagnostic or interventional procedures

Who cannot join

  • hemodynamic instability, age <18 years

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Ospedale Sandro Pertini - ASL RMB

    Rome, RM, 00168

Other trials in Italy

About this study

Radiation issue during percutaneous coronary interventions is an important issue for operators due to the long term stochastic risk of cancer induction, but is often under-evaluated. Many factors may be associated with the radiation dose adsorbed by operators. In particular the most important are the position taken by the operator, the use of dedicated X-ray shield and the duration of the procedure. However other factors (as operator height or the angulation of the radiation tube) might have some important effects but are often under-evaluated .

Aim of our observational study is to evaluate the most important determinants of the radiation dose adsorbed by operators during different coronary procedures (diagnostic coronary angiography or percutaneous coronary interventions) and through different vascular accesses (right or left transradial approach or transfemoral approach).

Read more

All patients who underwent to percutaneous coronary diagnostic or interventional procedures will be enrolled in this observational study.

Each operator will be equipped with dedicated dosimeters placed at left wrist, at thorax level outside the lead apron and at head level to evaluate the radiation dose at crystalline. Effective doses delivered to patients will be expressed as dose area product (DAP) and measured in Gycm2.

Being tested
Radiation dose
Keywords
Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiation doseRadiation

    Radiation dose adsorbed by operators

Study groups in NCT01974453
Study groupRoleWhat they receive
Right transradialProcedures performed through right transradial approach
Receives: Radiation: Radiation dose
Left transradialProcedures performed through left transradial approach
Receives: Radiation: Radiation dose
FemoralProcedures performed through transfemoral approach
Receives: Radiation: Radiation dose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiation Dose adsorbed by operators

    Radiation Dose adsorbed by operators

    Measured: Periprocedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Nov 2013 (estimated)
  2. Study startAug 2012
  3. Primary completionFeb 2016
  4. Study completionFeb 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,028 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT01974453
Sponsor's protocol ID
Pertini3
Acronym
RADIANT
Status last verified
Apr 2017
First submitted
26 Oct 2013
Last updated
6 Apr 2017
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Radiation Exposure, run by Ospedale Sandro Pertini, Roma at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiation Dose adsorbed by operators (time frame: Periprocedural). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in